PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33977847-0	2021	Computational and experimental insights on the interaction of artemisinin, dihydroartemisinin and chloroquine with SARS-CoV-2 spike protein receptor-binding domain (RBD).	artemisinin	62-73	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	126-131	
34306988-3	2021	Our in silico approach suggested that unique phytocompounds such as emodin, thymol and carvacrol, and artemisinin could physically bind SARS-CoV-2 spike glycoproteins (6VXX and 6VYB), SARS-CoV-2 B.1.351 South Africa variant of Spike glycoprotein (7NXA), and even with ACE2 and prevent the SARS-CoV-2 binding to the host ACE2, TMPRSS2 and neutrapilin-1 receptors.	artemisinin	102-113	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	147-152	
32696720-0	2021	Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19.	artemisinin	19-30	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	126-131	
32696720-5	2021	Artesunate, artemisinin and artenimol, showed two mode of interactions with Lys353 and Lys31 binding hotspots of the Spike protein.	artemisinin	12-23	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	117-122	
34585460-9	2022	The 50% effective concentration (EC50 ) of artemisinin against SARS-CoV-2 Spike pseudovirus was found greater than 50 muM (EC45 ) in HEK293T cell line whereas the cell viability was 94% of the control (P < 0.01).	artemisinin	43-54	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	74-79	
34306988-4	2021	Since Chloroquine has been looked as potential therapy against COVID-19, we also compared the binding of chloroquine and artemisinin for its interaction with spike proteins (6VXX, 6VYB) and its variant 7NXA, respectively.	artemisinin	121-132	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	158-163